Winrevair (Sotatercept)

Winrevair (sotatercept-csrk) is an activin signaling inhibitor used for the treatment of adult patients with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise potential, improve WHO functional class (FC) and scale down the probability of clinical worsening events.

Recommended Dosage: Winrevair is administered once every three weeks by subcutaneous injection according to the patient’s body weight. The recommended starting dose is 0.3 mg/kg and the target dose is 0.7 mg/kg. Dosage modifications because of increased hemoglobin (Hgb) and decreased platelets may be important. Check Hgb and platelets before each dose for the initial five doses, or longer if values are unstable, and monitor periodically thereafter.

If a dose is missed, administer it as quickly as possible. If the missed dose is not administered within 3 days of the scheduled date, adjust the schedule to maintain three-week dosing intervals. In case of an overdose, monitor for erythrocytosis.

• Treatment with Sotatercept 45 mg/60 mg may increase hemoglobin. Severe erythrocytosis may increase the probability of thromboembolic events or hyperviscosity syndrome. Monitor Hgb before each dose for the initial five doses, or longer in case values are unstable, and periodically thereafter, to specify if dose adjustments are required.
• Winrevair may decrease platelet count. Serious thrombocytopenia may increase the probability of bleeding. Do not start treatment if the platelet count is <50,000/mm3. Monitor platelets prior to each dose for the first 5 doses, or longer if values are unstable, and periodically thereafter to specify whether dose adjustments are needed.
• Serious bleeding (e.g., gastrointestinal, intracranial hemorrhage) may occur in patients taking treatment with Sotatercept-csrk. Assess and treat bleeding accordingly. Avoid administering this medicine if the patient is experiencing severe bleeding.
• Winrevair may be responsible for causing fetal harm when administered to a pregnant woman. e Females of reproductive age/potential should use an effective method of contraception during treatment and for at least four months after the final dose.

What documents are required to import WINREVAIR to India?

WINREVAIR (sotatercept-csrk) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)
• How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
  
• Import permit if applicable
  

Is WINREVAIR available in India?

WINREVAIR (sotatercept-csrk injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

• IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
  
• On availability of Winrevair in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.
  

WINREVAIR can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of WINREVAIR (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Winrevair 45 mg/60 mg price in India. 

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the WINREVAIR (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Winrevair®?

Sotatercept-csrk is a Generic Name for the trade name drug Winrevair®.

What is the manufacturer’s name for Winrevair®?

Winrevair® is manufactured by Merck Sharp & Dohme.

Is Winrevair® approved by the FDA?

Yes, Winrevair® is approved by the FDA. Date of first approval: March 26, 2024.

What is the dosage and form of Winrevair® supplied?

Winrevair® is supplied for injection: 45 mg/60 mg lyophilized cake or powder in a single-dose vial for subcutaneous use. 

What are the most common side effects due to Winrevair®? 

The most common side effects due to Winrevair® are rash, headache, epistaxis, telangiectasia, dizziness, diarrhea, and erythema.

How much does Winrevair® cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on the cost of Winrevair injection in India, it is recommended to Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Winrevair® be made available in SAARC countries? 

Apart from Gulf countries, Winrevair® can be available in SAARC countries (Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, India, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the supply of Winrevair® in these countries, ensuring access to this therapeutic through legal and reliable channels.

What are the storage conditions of Winrevair®?

Store vials refrigerated at 2-8°C (36-46°F) in the original carton to protect from light. It is not advisable to freeze it. 

Is it safe to buy Winrevair® online in India?

Yes, one can buy Winrevair online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in the country. We can help facilitate the supply of Winrevair® through legal channels.